OABI Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: March 24, 2026
Report Source: 2025 Annual Report
OmniAb Inc. Stock Analysis OABI
OmniAb, Inc. operates as a drug discovery company. The company is headquartered in Emeryville, California and currently employs 89 full-time employees. The company went IPO on 2020-10-09. Its technology platform creates and screens diverse antibody repertoires and is designed to identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. Central to the OmniAb platform, Biological Intelligence, powers the immune systems of its engineered transgenic animals to create optimized antibody candidates for human therapeutics. Its proprietary transgenic animals, including OmniRat, OmniChicken and OmniMouse are genetically modified to generate antibodies with human sequences to streamline the development of human therapeutic candidates. OmniFlic and OmniClic are fixed or common light-chain rats and chickens, designed to facilitate the discovery of bispecific antibodies. OmniTaur provides cow-inspired antibodies with unique structural characteristics for challenging targets.
Read More OmniAb Inc (OABI) Chart
Key Statistics of OmniAb Inc (OABI)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$2.15Volume
915.65KP/E Ratio (TTM)
-52 Week Range
Market Cap
202.70MAvg. Volume
900.35KDividend Yield
-Financial Metrics & Statements of OmniAb Inc (OABI)
FAQ's for OmniAb Inc (OABI)
- According to Musaffa’s Shariah screening methodology, OmniAb Inc (OABI) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.